BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 17854315)

  • 1. Antiphospholipid antibody syndrome: the flow cytometric annexin A5 competition assay as a diagnostic tool.
    Tomer A; Bar-Lev S; Fleisher S; Shenkman B; Friger M; Abu-Shakra M
    Br J Haematol; 2007 Oct; 139(1):113-20. PubMed ID: 17854315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
    Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of Antiphospholipid syndrome using Annexin A5 competition assay in patients with SLE.
    Avriel A; Fleischer S; Friger M; Shovman O; Neuman G; Shoenfeld Y; Abu-Shakra M
    Clin Rheumatol; 2016 Dec; 35(12):2933-2938. PubMed ID: 27704312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of antiphospholipid antibodies in lupus nephritis.
    Natejumnong C; Ruangkanchanasetr P; Aimpun P; Supaporn T
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S121-8. PubMed ID: 17044463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antiphospholipid syndrome and stroke].
    Kitagawa Y
    Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of anti-cardiolipin antibodies and IVIg on annexin A5 binding to endothelial cells: implications for cardiovascular disease.
    FrostegÄrd AG; Su J; von Landenberg P; FrostegÄrd J
    Scand J Rheumatol; 2010; 39(1):77-83. PubMed ID: 20132075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of thrombin antibodies in patients with antiphospholipid syndrome.
    Miesbach W; Matthias T; Scharrer I
    Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revisiting antiphospholipid antibodies: from targeting phospholipids to phospholipid binding proteins.
    Bertolaccini ML; Hughes GR; Khamashta MA
    Clin Lab; 2004; 50(11-12):653-65. PubMed ID: 15575307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory evaluation of the antiphospholipid syndrome.
    Abo SM; DeBari VA
    Ann Clin Lab Sci; 2007; 37(1):3-14. PubMed ID: 17311864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real world experience with antiphospholipid antibody tests: how stable are results over time?
    Erkan D; Derksen WJ; Kaplan V; Sammaritano L; Pierangeli SS; Roubey R; Lockshin MD
    Ann Rheum Dis; 2005 Sep; 64(9):1321-5. PubMed ID: 15731290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical laboratory testing for the antiphospholipid syndrome.
    Pierangeli SS; Harris EN
    Clin Chim Acta; 2005 Jul; 357(1):17-33. PubMed ID: 15893301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiphospholipid antibody ELISAs: survey on the performance of clinical laboratories assessed by using lyophilized affinity-purified IgG with anticardiolipin and anti-beta2-Glycoprotein I activity.
    Pengo V; Biasiolo A; Bison E; Chantarangkul V; Tripodi A;
    Thromb Res; 2007; 120(1):127-33. PubMed ID: 17020782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of the first fully automated method for anti-cardiolipin and anti-beta2 glycoprotein I antibody detection for the diagnosis of antiphospholipid syndrome.
    Villalta D; Alessio MG; Tampoia M; Da Re A; Stella S; Da Re M; Tozzoli R; Bizzaro N
    Ann N Y Acad Sci; 2009 Sep; 1173():21-7. PubMed ID: 19758127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diluted Russell viper-venom time improves identification of antiphospholipid syndrome in a lupus anticoagulant-positive patient population.
    Lambert M; Ferrard-Sasson G; Dubucquoi S; Hachulla E; Prin L; Hatron PY; Goudemand J; Boffa MC; Caron C
    Thromb Haemost; 2009 Mar; 101(3):577-81. PubMed ID: 19277423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticardiolipin, other antiphospholipid antibody tests and diagnosis of the antiphospholipid syndrome.
    Smikle M; Wharfe G; Fletcher H; Reid M; Roye-Green K; Fredrick J; Pierangeli S
    Hum Antibodies; 2003; 12(3):63-6. PubMed ID: 14646034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid syndrome: diagnostic aspects of lupus anticoagulants.
    Arnout J
    Thromb Haemost; 2001 Jul; 86(1):83-91. PubMed ID: 11487046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory tests for the antiphospholipid syndrome: current concepts.
    Passam F; Krilis S
    Pathology; 2004 Apr; 36(2):129-38. PubMed ID: 15203748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A flow cytometric assay for the detection of antiphospholipid antibodies.
    Pierangeli SS; Silva LK; Harris EN
    Am Clin Lab; 1999 Jul; 18(6):18-9. PubMed ID: 10557848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.